Meeting
2024 ASCO Breakthrough
CORRECT-MRD I: A clinical validation study to predict recurrence in stage II-III colorectal cancer (CRC) using a bespoke circulating tumor DNA (ctDNA) assay to detect molecular residual disease (MRD).
Authors
Yuichiro Tsukada
National Cancer Center Hospital East, Kashiwa, Japan
Yuichiro Tsukada , Tamotsu Sagawa , Gopalakrishnan Srinivasan , Ayala Hubert , Ofer Purim , Valeriya Semenisty , Nangi Lo , Giuseppe Mondello , Antonio Cubillo Gracian , Tara Marti , Somasundaram Subramaniam , Melanie R. Palomares , Frederick Baehner , Floris A de Jong , David James Kerr , Takayuki Yoshino
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session A
Track
Gastrointestinal Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Quality of Care,Healthcare Equity and Access to Care,Population Health,Viral-Mediated Malignancies
Sub Track
Early Detection and Surveillance
Citation
J Clin Oncol 42, 2024 (suppl 23; abstr TPS98)
DOI
10.1200/JCO.2024.42.23_suppl.TPS98
Abstract #
TPS98
Poster Bd #
L7
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Impact of postoperative integrated genomic and epigenomic signatures of circulating tumor DNA (ctDNA) on recurrence in resected colorectal cancer: Initial report of a prospective ctDNA monitoring study COSMOS-CRC-01.
First Author: Yuichiro Tsukada
Poster
2020 ASCO Virtual Scientific Program
Circulating tumor DNA as a promising biomarker of relapse risk for stage II-III colorectal cancer.
First Author: Gong Chen
Poster
2024 ASCO Annual Meeting
Individualized tumor-informed circulating tumor DNA analysis for molecular residual disease detection in predicting recurrence and efficacy of adjuvant chemotherapy in colorectal cancer.
First Author: Di Cao
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Comprehensive genomic analysis of molecular residual disease based on circulating tumor DNA in patients with postoperative colorectal cancer.
First Author: Qingqi Hong